These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 33045965)
41. CRISPR-Cas9 technology and its application in haematological disorders. Zhang H; McCarty N Br J Haematol; 2016 Oct; 175(2):208-225. PubMed ID: 27619566 [TBL] [Abstract][Full Text] [Related]
42. CRISPR/Cas9: A revolutionary genome editing tool for human cancers treatment. Akram F; Haq IU; Sahreen S; Nasir N; Naseem W; Imitaz M; Aqeel A Technol Cancer Res Treat; 2022; 21():15330338221132078. PubMed ID: 36254536 [TBL] [Abstract][Full Text] [Related]
43. Advance genome editing technologies in the treatment of human diseases: CRISPR therapy (Review). Alagoz M; Kherad N Int J Mol Med; 2020 Aug; 46(2):521-534. PubMed ID: 32467995 [TBL] [Abstract][Full Text] [Related]
44. CRISPR/Cas9 gene editing therapies for cystic fibrosis. Graham C; Hart S Expert Opin Biol Ther; 2021 Jun; 21(6):767-780. PubMed ID: 33412935 [TBL] [Abstract][Full Text] [Related]
45. CRISPR/Cas9-mediated noncoding RNA editing in human cancers. Yang J; Meng X; Pan J; Jiang N; Zhou C; Wu Z; Gong Z RNA Biol; 2018 Jan; 15(1):35-43. PubMed ID: 29028415 [TBL] [Abstract][Full Text] [Related]
46. CRISPR/Cas9-Mediated Genome Editing in Cancer Therapy. Ding S; Liu J; Han X; Tang M Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003514 [TBL] [Abstract][Full Text] [Related]
47. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum. Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843 [TBL] [Abstract][Full Text] [Related]
48. Challenges of in vitro genome editing with CRISPR/Cas9 and possible solutions: A review. Ebrahimi V; Hashemi A Gene; 2020 Aug; 753():144813. PubMed ID: 32470504 [TBL] [Abstract][Full Text] [Related]
49. Can genetic engineering-based methods for gene function identification be eclipsed by genome editing in plants? A comparison of methodologies. Amritha PP; Shah JM Mol Genet Genomics; 2021 May; 296(3):485-500. PubMed ID: 33751237 [TBL] [Abstract][Full Text] [Related]
54. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells. Zhang Y; Sastre D; Wang F Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747 [TBL] [Abstract][Full Text] [Related]
55. The CRISPR/Cas9 system and its applications in crop genome editing. Bao A; Burritt DJ; Chen H; Zhou X; Cao D; Tran LP Crit Rev Biotechnol; 2019 May; 39(3):321-336. PubMed ID: 30646772 [TBL] [Abstract][Full Text] [Related]
56. Application of the genome editing tool CRISPR/Cas9 in non-human primates. Luo X; Li M; Su B Dongwuxue Yanjiu; 2016 Jul; 37(4):214-9. PubMed ID: 27469252 [TBL] [Abstract][Full Text] [Related]
57. Delivery of CRISPR/Cas9 by Novel Strategies for Gene Therapy. Wang L; Zheng W; Liu S; Li B; Jiang X Chembiochem; 2019 Mar; 20(5):634-643. PubMed ID: 30393919 [TBL] [Abstract][Full Text] [Related]
58. Genome Editing by CRISPR/Cas9 in Sorghum Through Biolistic Bombardment. Liu G; Li J; Godwin ID Methods Mol Biol; 2019; 1931():169-183. PubMed ID: 30652290 [TBL] [Abstract][Full Text] [Related]
59. CRISPR/Cas9-mediated correction of human genetic disease. Men K; Duan X; He Z; Yang Y; Yao S; Wei Y Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256 [TBL] [Abstract][Full Text] [Related]
60. Analysis of microsatellite instability in CRISPR/Cas9 editing mice. Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]